GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD17B1, HSD17B2, KDR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, SLC1A1, SRC, TNKS, TNKS2, XDH |
11.4686 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, HMGCR, HSD17B1, HSD17B2, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
11.1877 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTAFR, PTGS2, RORC, SRC, TYR |
8.99342 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP2, PIK3CA, PPARA, PTAFR, PTGS2, RORC, SRC, TYR |
8.8953 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ABCG2, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTAFR, PTGS2, RORC, SRC, TYR |
8.8953 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HMGCR, PIK3CA, PIM1, PPARA, PTAFR, PTGS1, PTGS2, TYR, XDH |
8.8953 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
8.4906 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
8.48494 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.43676 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
7.74204 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
7.5849 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
7.45523 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC |
7.3137 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
7.31115 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HMGCR, HSD17B1, HSD17B2 |
7.31115 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, HMGCR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.30823 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
7.07863 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CSNK2A1, CYP1B1, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
7.07863 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5, PTAFR |
7.02971 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.89651 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, XDH |
6.75157 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FLT3, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
6.73669 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, RORC, SRC |
6.53681 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, PIK3CA, PTAFR, PTGS2, RORC, SRC |
6.53681 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS1, PTGS2, SRC, XDH |
6.53681 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, TYR |
6.53681 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
6.53681 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT, PTGS2 |
6.53681 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
6.53681 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CYP1B1, FLT3, GRM1, HMGCR, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.52266 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
6.41681 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TNKS, TNKS2 |
6.31928 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.28898 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CSNK2A1, CYP1B1, FABP4, FLT3, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.288 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTAFR, PTGS2, RORC, SRC, TNKS2, TYR |
6.288 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
6.11686 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
6.05695 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.02105 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PTAFR, PTGS2, RORC, SRC, TYR |
5.95656 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.93864 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, RORC, SRC, TYR |
5.92404 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.85535 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.81249 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.81249 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
5.81249 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.81249 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, GRM5, IGF1R, KIT, MMP2, PPARA, PTAFR, PTGS2, SRC |
5.77752 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, RORC, SRC |
5.75713 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.70093 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
5.6812 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTAFR, PTGS2, PTPN1, RORC, SRC |
5.30727 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.27737 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.24551 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.24551 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.2243 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRIK5, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.19251 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, RORC, SRC, TYR |
5.16205 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.00824 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
4.98888 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, CDC25B, CSNK2A1, ESR1, FLT3, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2 |
4.89362 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS1, PTGS2 |
4.89362 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, HMGCR, KIT, PPARA, PTGS2, RORC, SRC |
4.88274 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, KIT, PPARA, PTAFR, PTGS2, SRC |
4.86239 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
4.8102 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
4.7846 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC |
4.76286 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.70647 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, KDR, KIT, PIK3CA, PPARA, PTPRS, SRC, TYR |
4.70042 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, CDC25B, ESR1, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
4.68616 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
4.67613 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
4.58747 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HMGCR, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, TNKS2, TYR |
4.58747 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, SRC |
4.56906 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, CDC25B, CSNK2A1, ESR1, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
4.56906 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.56263 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
4.52026 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.52026 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.50284 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2 |
4.48947 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
4.48668 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, FLT3, GRM1, HMGCR, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
4.43106 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, HMGCR, PTAFR, TYR |
4.42803 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
4.39499 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
4.39232 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.37462 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
4.28635 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
4.24565 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
4.17774 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
4.17774 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, RORC, SRC |
4.17774 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, ESR1, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
4.16238 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.13836 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, GRM5, PTAFR |
4.12664 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.09628 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
4.09437 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.00708 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, CA12, CA2, CA7, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB |
3.94113 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, HMGCR, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
3.93394 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, KIT, MET, PIK3CA, PIK3CB, SRC, XDH |
3.9319 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
3.93047 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, ESR1, FLT3, GRM1, GRM5, HMGCR, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
3.93047 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
3.91203 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.87169 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, FLT3, GRM1, HMGCR, IGF1R, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
3.80716 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, KIT, MET, PIK3CA, PIK3CB, SRC |
3.80694 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
3.774 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
3.74611 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
3.74611 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ABCG2, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, FABP3, HMGCR, KDR, PTAFR, PTGS2, SRC |
3.70983 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HMGCR, HSD17B1, HSD17B2 |
3.6932 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.68612 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, GRM1, HMGCR, KIT, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
3.68071 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, HMGCR, PTAFR, TYR |
3.65576 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGS2, SRC |
3.61219 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, XDH |
3.60599 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.56143 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.53214 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
3.5101 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.50832 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.50832 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.50832 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.50832 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
3.50832 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, ESR1, FLT3, KIT, MET, PIK3CB, PIM1, SRC, TYR |
3.49865 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, KIT, PIK3CA, PIK3CB, PTAFR, PTGS1, PTGS2 |
3.48129 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.46419 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, KIT, PIK3CB, PTPN1, SRC |
3.461 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, HMGCR, PTAFR, PTGS1, PTGS2 |
3.45605 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTPN1, RORC, SRC, TNKS, TNKS2 |
3.44764 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
3.43787 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
3.43668 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, GRIK5, GRM5, HMGCR, MMP12, MMP9, PIK3CB, PPARA, PTAFR, PTGS2, PTPN1, SRC |
3.41721 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.39611 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TNKS |
3.37639 |
[BP] GO:0010359 |
None
|
ABCB1, GRM5, PTAFR |
3.37639 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.37639 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3, HMGCR |
3.36804 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, ESR1, FLT3, GRM5, IGF1R, KIT, MMP2, PTAFR, PTGS2, SRC |
3.35474 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, HSD17B2, KDR, KIT, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, TYR |
3.3512 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
3.3512 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.3512 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.3111 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HMGCR |
3.3111 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.30127 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
3.29962 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
3.29962 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.27059 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27059 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, HMGCR |
3.27059 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, CDC25B, ESR1, FLT3, GRM1, GRM5, KIT, MET, MMP9, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TNKS, XDH |
3.26992 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
3.2551 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.24716 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
3.22006 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, XDH |
3.21253 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.18742 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.14214 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.13007 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.11848 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, ESR1, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC, XDH |
3.10152 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TNKS |
3.09296 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
3.07019 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, FABP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, XDH |
3.06116 |
[BP] GO:0070542 |
None
|
AKR1C3, FABP3, PTAFR, PTGS2, SRC |
3.04954 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
2.99151 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.97892 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, KIT, PTAFR, PTGS2 |
2.97729 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, FABP3, FABP4, KIT, MET, PIK3CA, PIK3CB |
2.97536 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.97245 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.97158 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
2.96613 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.94807 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.93263 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.93263 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.93263 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.93263 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.92591 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, PIK3CB, PTGS2, TNKS, TNKS2 |
2.89291 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.86416 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.84974 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, GRM5, KIT, PTPN1, SRC |
2.84104 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.7693 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.736 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.71054 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.70051 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.70051 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, ESR1, FLT3, GRM1, GRM5, KIT, PIK3CA, PIK3CB, PTAFR, PTPN1, SRC, TNKS, XDH |
2.70051 |
[BP] GO:0051179 |
None
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, ESR1, FABP3, GRIA2, GRIA4, GRIK5, KIT, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TNKS, TNKS2, XDH |
2.69416 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
2.68136 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.62401 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, IGF1R, PPARA, PTGS2, SRC |
2.61236 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.60384 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, KIT, PTPN1, SRC |
2.5717 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.55941 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.55664 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.53158 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.52612 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.52612 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.52612 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.52612 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.52612 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52612 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.52612 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, KIT, PIK3CB, PTPN1, SRC |
2.52612 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, CSNK2A1, ESR1, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.47403 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, CYP19A1, ESR1, HSD17B2, KIT, SRC |
2.47403 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.47291 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9 |
2.4629 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.4524 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, KIT, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, SRC |
2.44972 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTAFR, PTGS2, SRC |
2.43842 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP1B1, HMGCR, PTAFR |
2.42324 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.41637 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.39783 |
[BP] GO:1903959 |
None
|
ABCB1, GRM5, PTAFR |
2.39783 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.39783 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, APP, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, HSD17B2, KIT, MMP2, MMP9, PTAFR, PTGS2, SRC |
2.39783 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.38908 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, ESR1, KIT, MMP12, MMP2, PIK3CA, PIK3CB, PTAFR, PTPN1, PTPRS, SRC |
2.38812 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KDR, PTAFR, PTGS2, SRC |
2.37809 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AURKB, CSNK2A1, ESR1, FABP4, GRM3, GRM8, HMGCR, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.37809 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.36741 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, KIT, PPARA, RORC, SRC |
2.36364 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.36112 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, KIT, PIK3CB, PTPN1, SRC |
2.36029 |
[BP] GO:0006810 |
None
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, KIT, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TNKS, XDH |
2.35811 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
IGF1R, PIK3CA, PIK3CB, PTAFR |
2.34727 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.33483 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.32903 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, GRM5, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.32375 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, AKR1C3, APP, CYP1B1, GRM1, GRM5, GRM8, HMGCR, KIT, PIK3CA, PTAFR, PTGS2, SRC, TYR |
2.32278 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31207 |
[BP] GO:0042391 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.30059 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.30059 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.30059 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.30059 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.30059 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30059 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.29715 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
IGF1R, PIK3CA, PIK3CB, PTAFR |
2.29715 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.29064 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PTGS2, PTPRS |
2.2839 |
[BP] GO:0051234 |
None
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, KIT, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TNKS, XDH |
2.28321 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, ESR1, GRM1, HMGCR, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PTAFR, PTGS2, PTPRS, SLC1A1, SRC, TNKS2, XDH |
2.2804 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.2804 |
[BP] GO:0006940 |
None
|
ADORA1, KIT, PTAFR, PTGS2 |
2.2804 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.28008 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.27744 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC |
2.27378 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ABCG2, APP, CA2, CA7, ESR1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB |
2.26369 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, XDH |
2.23646 |
[BP] GO:0048169 |
None
|
APP, GRM5, KIT |
2.23509 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.20274 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.19547 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.19547 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.19547 |
[BP] GO:0006693 |
None
|
AKR1C3, PTGS1, PTGS2 |
2.19547 |
[BP] GO:0006692 |
None
|
AKR1C3, PTGS1, PTGS2 |
2.19547 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, APP, CA12, CA2, CA7, ESR1, FABP3, GRM1, GRM5, PIK3CB |
2.19547 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, GRM1, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.16501 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.15748 |
[BP] GO:0007612 |
None
|
APP, GRM5, HMGCR, KIT, PTGS2 |
2.15626 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.15626 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.15626 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, PIK3CB, PTPN1, SRC |
2.15495 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, CA2, FLT3, PTAFR, PTGS2, SRC |
2.15495 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, GRM5, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.14883 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.14711 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.14638 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, AKR1C3, APP, CA2, ESR1, GRM1, GRM3, GRM5, GRM8, PIK3CA, PIK3CB, PTAFR, SRC |
2.14638 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.13894 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.13894 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13119 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.12306 |
[BP] GO:0061097 |
None
|
ADORA1, APP, GRM5, PTPN1 |
2.11307 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.10771 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.08519 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, CYP19A1, ESR1, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SRC, XDH |
2.06791 |
[BP] GO:0032845 |
None
|
ADORA1, HMGCR, SRC, TNKS, TNKS2 |
2.06764 |
[BP] GO:0010631 |
epithelial cell migration
|
CYP1B1, KDR, KIT, PIK3CA |
2.0556 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.0556 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.04765 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.04765 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.03741 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, KIT, MET, PIK3CA, PIK3CB |
2.02379 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.01949 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.01949 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, MMP9 |
2.0127 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.0127 |
[BP] GO:0008217 |
None
|
ADORA1, PPARA, PTAFR, PTGS1, PTGS2 |
2.01236 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.01099 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.00644 |
[BP] GO:1903961 |
None
|
ABCB1, PTAFR |
2.00376 |
[BP] GO:1904306 |
None
|
KIT, PTAFR |
2.00376 |
[BP] GO:1904304 |
None
|
KIT, PTAFR |
2.00376 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.00376 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.00376 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ABCG2, ADORA1, CA2, CA4, CA9, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
5.07272 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTPN1, PTPRS, SLC1A1, SRC |
4.94666 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ABCG2, ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PTAFR, PTGS2, PTPRS, SLC1A1, SRC |
4.67066 |
[CC] GO:0016020 |
membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, SLC1A1, SRC, TNKS, TNKS2, TYR |
4.28635 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.48129 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, PTPRS, SRC, TUBB3 |
3.42351 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, SLC1A1, SRC, TYR |
3.35729 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SRC |
3.29962 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1 |
3.08616 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1 |
2.75187 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.52977 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.36741 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.34322 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.34322 |
[CC] GO:0014069 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32545 |
[CC] GO:0099572 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32545 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.32405 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, HMGCR, HSD17B1, HSD17B2, KDR, KIT, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.31207 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS1, PTGS2, PTPRS, SRC, TUBB3 |
2.29394 |
[CC] GO:0043226 |
organelle
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, AURKB, AXL, CA1, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
2.15495 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, APP, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GRIA4, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
2.14638 |
[CC] GO:0043235 |
receptor complex
|
ABCG2, APP, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.12107 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00376 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
11.2694 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ABCG2, ACHE, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTAFR, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
10.0879 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
10.0033 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.0003 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.24257 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
7.3969 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.35042 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.56733 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, TNKS |
5.33299 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
5.13452 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR |
4.76286 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.70647 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
4.52026 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HMGCR, HSD17B1, HSD17B2 |
4.40097 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
4.37462 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TYR, XDH |
4.29071 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.22218 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.20013 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TYR, XDH |
4.05106 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.0421 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ABCG2, ALOX15, APP, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TUBB3, XDH |
4.0279 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
3.87998 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
3.85855 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.80701 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.74611 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
3.68612 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.68581 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.56143 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.39938 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.36744 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, ESR1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PPARA, PTAFR, RORC |
3.35373 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ABCG2, ADORA1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SLC1A1, SRC, TUBB3, XDH |
3.34157 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PTAFR |
3.29412 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, PTAFR |
3.29412 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.14902 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.93263 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.93263 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC |
2.86416 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.85513 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, XDH |
2.81329 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.77589 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, APP, CSNK2A1, ESR1, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, MMP9, NQO2, PTGS2, TYR, XDH |
2.58036 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.52612 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.52612 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.52612 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.52612 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.51647 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5121 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5121 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.5022 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TUBB3, XDH |
2.32375 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TUBB3, XDH |
2.32375 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.30059 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.26117 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.23509 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.19547 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.19547 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.19547 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ABCG2, ADORA1, APP, AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTAFR, PTPRS, SRC, TUBB3 |
2.19134 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.15626 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.15626 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.11307 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.08655 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.08519 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.0127 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.01046 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00376 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.00376 |